Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-000922
Filing Date
2023-05-08
Accepted
2023-05-08 16:02:13
Documents
73
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20230331x10q.htm   iXBRL 10-Q 1746312
2 EX-10.32 tmb-20230331xex10d32.htm EX-10.32 50279
3 EX-10.33 tmb-20230331xex10d33.htm EX-10.33 49786
4 EX-31.1 tmb-20230331xex31d1.htm EX-31.1 10725
5 EX-31.2 tmb-20230331xex31d2.htm EX-31.2 10717
6 EX-32.1 tmb-20230331xex32d1.htm EX-32.1 5465
  Complete submission text file 0001410578-23-000922.txt   7929740

Data Files

Seq Description Document Type Size
7 EX-101.SCH tmb-20230331.xsd EX-101.SCH 65777
8 EX-101.CAL tmb-20230331_cal.xml EX-101.CAL 51849
9 EX-101.DEF tmb-20230331_def.xml EX-101.DEF 238886
10 EX-101.LAB tmb-20230331_lab.xml EX-101.LAB 435158
11 EX-101.PRE tmb-20230331_pre.xml EX-101.PRE 396631
67 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20230331x10q_htm.xml XML 1354573
Mailing Address 55 ADMINISTRATION ROAD, UNIT 13 VAUGHAN A6 L4K-4G9
Business Address 55 ADMINISTRATION ROAD, UNIT 13 VAUGHAN A6 L4K-4G9 905-541-3833
Target Group Inc. (Filer) CIK: 0001586554 (see all company filings)

EIN.: 463610035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55066 | Film No.: 23897621
SIC: 2833 Medicinal Chemicals & Botanical Products